Abstract
purpose. Ocular side effects in patients using eye drops may be due to intolerance to the vector used in eye drops. Castor oil is the commonly used lipophilic vector but has been shown to be cytotoxic. Effects on cells of four oils (olive, camelina, Aleurites moluccana, maize) were compared with those of castor oil in human conjunctival cells.
methods. Human conjunctival cells were incubated with the oils for 15 minutes. After a 24-hour recovery period, cells were tested for viability, proliferation, apoptosis (P2X7 cell death receptor and caspase 3 activation), intracellular redox potential, and reactive oxygen species production. Fatty acid incorporation in cell membranes was also analyzed. In vivo ocular irritation was assessed using the Draize test.
results. Compared to the four other oils, castor oil was shown to induce significant necrosis and P2X7 cell death receptor and caspase 3 activation and to enhance intracellular reactive oxygen species production. Aleurites moluccana and camelina oils were not cytotoxic and increased cell membrane omega-3 fatty acid content. None of the five tested oils showed any in vivo ocular irritation.
conclusions. The results demonstrated that castor oil exerts cytotoxic effects on conjunctival cells. This cytotoxicity could explain the side effects observed in some patients using eye drops containing castor oil as a vehicle. The lack of cytotoxic effects observed with the four other oils, Aleurites, camelina, maize, and olive, suggest that they could be chosen to replace castor oil in ophthalmic formulations.
Topical drug administration is very often used to treat ocular surface and intraocular disease, providing higher local drug levels than systemic administration,
1 with minimal general side effects.
2 The therapeutic efficacy of a topical formulation depends on both its composition and the physicochemical properties of the vehicle. Use of an appropriate vehicle is critical to increase the optimal efficacy of the pharmacologically active drug.
3 Most commercialized eye drops are prepared in aqueous form, although most active components are lipophilic. Another drawback of the hydrophilic formulations is the fast elimination of the eye drop by tears, reducing contact duration between the drug and the ocular tissue.
The use of a lipophilic vehicle in eye drops increases solubility and pharmacologic effects of the drug. An improvement of the cell delivery of drugs using vector oil is based on the modulation of membrane fluidity that directly depends on its fatty acid composition. Castor oil, which mainly contains ricinoleic acid (90% of total fatty acid content),
4 is one of the lipophilic vehicles used in cyclosporine eye drops.
2 5 6 However, it presents both a low-stability and an epithelial and conjunctival toxicity
7 as well as systemic adverse effects such as purgative effects, hypersensitivity, nephrotoxicity, and neurotoxicity.
4 8 Since castor oil is presumed to be responsible for cytotoxic effects in the eye, its replacement by another lipophilic vector could result in better tolerance of the drops.
Omega-3 fatty acids are important in the structure and function of the visual system.
9 α-Linolenic acid (ALA) is the precursor of the long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA)—mainly, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)
10 —found in fish oils and in nerve tissue cell membranes. Several vegetable oils exhibit a high content of omega-3 fatty acids. For instance,
Aleurites moluccana and camelina oils are rich sources of linolenic acid (36%–40%).
11 12 Long-chain omega-3 fatty acids are rapidly incorporated into cell membrane phospholipids, thereby resulting in changes in receptor functions and alteration in cell signaling mechanisms and membrane-bound enzymes.
13 On the other hand, incorporation of α-linolenic acid or other n-3 series fatty acids into the diet results in marked changes in cell membrane composition as well as in arachidonic acid metabolism.
14 Arachidonic acid, a long-chain omega-6 polyunsaturated fatty acid (n-6 PUFA) abundant in membrane phospholipids, is the first step of the inflammatory process after metabolism by cyclooxygenases and lipoxygenases, which are present in the conjunctiva.
15 16 The omega-3 fatty acids contained in vegetable oils, such as camelina oil, could thus replace arachidonic acid in cell membranes and decrease inflammation. Therefore, it is of interest to develop lipophilic vectors that would be free of negative side effects and contain omega-3 fatty acids.
In this study, we evaluated the in vitro and in vivo toxicity of four vegetable oils to validate their use as vehicles of lipophilic drugs in eye drops. They were chosen because of their biological properties and fatty acid composition
11 17 18 : Two of them are rich in omega-3 fatty acids (Aleurites and camelina) and two are free of omega-3 (maize and olive). The olive oil was highly refined (neutral, denatured, and free of antioxidants) and was chosen as the negative control; castor oil was tested to confirm its cytotoxic effects in our cell model. Cell assays for necrosis, apoptosis, intracellular redox status, and antioxidant properties were performed on human conjunctival cells. In addition, we analyzed the incorporation of oils (i.e., of their constitutive fatty acids) in cultured conjunctival epithelial cell membranes. In vivo ocular irritation was evaluated by using the Draize test.
Wong Kilbourne–derived human conjunctival epithelial cells (WKD, ECACC 93120839) were cultured under standard conditions (moist atmosphere of 5% CO2 at 37°C) in Dulbecco’s minimum essential medium (DMEM; Eurobio, Les Ulis, France) supplemented with 10% fetal bovine serum (FBS, Eurobio), 2 mM l-glutamine, 50 IU/mL penicillin, and 50 IU/mL streptomycin (Eurobio). The culture medium was changed every 3 days; confluent cultures were removed by trypsin incubation. The cells were counted, seeded into 96-well microplates (Costar; VWR, Fontenay sous Bois, France), and kept at 37°C for 24 hours. The different undiluted oils, including olive oil as the control, were incubated for 15 minutes (30 minutes for the fatty acid incorporation test), and tests were performed after a 24-hour recovery period in culture medium. Olive oil was chosen as the control.
Fluorometry was performed with a microplate cold light cytofluorometer
19 (Fluorolite 1000; Dynex, Cergy Pontoise, France). All fluorescent dyes were added to living cells, since this method allows detection of the fluorescent signal directly from the microplate.
Membrane Integrity.
Redox Status.
Cell Proliferation.
P2X7 Cell Death Receptor Activation: the YO-PRO-1 Test.
YO-PRO-1, a DNA probe (Invitrogen-Molecular Probes, PoortGebouw, The Netherlands), penetrates apoptotic cells only through the P2X7 receptor. After incubation with the different oils, a 2-μM YO-PRO-1 solution in phosphate-buffered saline was applied (200 μL per well), and the microplate was placed for 10 minutes in the dark at room temperature. The fluorescence signal was scanned by using a cytofluorometer with a small band pass and precise wave lengths for YO-PRO-1 fluorescence detection (λex. = 491 nm; λem. = 509 nm). This test was simultaneously performed with the neutral red test.
Caspase 3 Activation.